NUVATION BIO INC's ticker is NUVB and the CUSIP is 67080N101. A total of 125 filers reported holding NUVATION BIO INC in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $29,556 | – | 16,420 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Omega Fund Management, LLC | 22,957,340 | $195,137,000 | 27.59% |
| Aisling Capital Management LP | 2,541,009 | $21,599,000 | 7.62% |
| EDBI Pte Ltd | 1,270,504 | $10,799,000 | 5.87% |
| EcoR1 Capital, LLC | 13,896,543 | $118,121,000 | 3.76% |
| Ally Bridge Group (NY) LLC | 1,197,152 | $10,176,000 | 3.56% |
| Boxer Capital, LLC | 4,341,009 | $36,899,000 | 1.43% |
| Avidity Partners Management LP | 7,382,488 | $62,751,000 | 1.33% |
| Baupost Group | 8,623,021 | $72,957,000 | 0.72% |
| Abrams Capital Management | 3,811,513 | $32,398,000 | 0.71% |
| Redmile Group, LLC | 3,671,009 | $31,204,000 | 0.71% |